Bristol-Myers Squibb to Hold Investor Webcast to Discuss ASH Highlights

Tuesday, November 26, 2019 6:59 am EST



Public Company Information:


NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) will hold an investor webcast on Sunday, December 8, 2019 at 8:00 p.m. ET to discuss data presented at the American Society of Hematology meeting, in Orlando. Company executives will provide an overview of data presented and address questions from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the event at Materials related to the event will be available at the same website prior to the event. A replay of the event will be available and can be accessed at

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at or follow us on LinkedIn, Twitter, YouTube, Facebook , and Instagram.

Multimedia Files:

Preview image



Tim Power, 609-252-7509,
Nina Goworek, 908-673-9711,


Privacy Policy
Business Wire NewsHQsm
Cookie Settings